Jonathan P. Sleeman

16.4k total citations · 2 hit papers
167 papers, 13.1k citations indexed

About

Jonathan P. Sleeman is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Jonathan P. Sleeman has authored 167 papers receiving a total of 13.1k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Molecular Biology, 70 papers in Oncology and 58 papers in Cell Biology. Recurrent topics in Jonathan P. Sleeman's work include Proteoglycans and glycosaminoglycans research (45 papers), Glycosylation and Glycoproteins Research (38 papers) and Lymphatic System and Diseases (28 papers). Jonathan P. Sleeman is often cited by papers focused on Proteoglycans and glycosaminoglycans research (45 papers), Glycosylation and Glycoproteins Research (38 papers) and Lymphatic System and Diseases (28 papers). Jonathan P. Sleeman collaborates with scholars based in Germany, United States and United Kingdom. Jonathan P. Sleeman's co-authors include Jean Paul Thiery, Peter Herrlich, Helmut Ponta, Wilko Thiele, Christian Termeer, Véronique Orian‐Rousseau, Jan C. Simon, Christina Fieber, Thomas Ahrens and Larry S. Sherman and has published in prestigious journals such as Cell, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Jonathan P. Sleeman

162 papers receiving 12.9k citations

Hit Papers

Complex networks orchestrate epithelial–mesenchymal trans... 2002 2026 2010 2018 2006 2002 1000 2.0k 3.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan P. Sleeman Germany 54 7.3k 4.7k 3.1k 2.3k 2.1k 167 13.1k
Shigeki Higashiyama Japan 64 8.2k 1.1× 4.4k 0.9× 2.6k 0.8× 2.0k 0.9× 2.1k 1.0× 279 15.6k
Arne Östman Sweden 63 9.8k 1.3× 4.6k 1.0× 1.6k 0.5× 2.9k 1.2× 2.9k 1.3× 165 16.8k
Ole W. Petersen Denmark 53 5.6k 0.8× 5.6k 1.2× 2.5k 0.8× 2.0k 0.9× 1.3k 0.6× 107 11.4k
Norbert E. Fusenig Germany 59 6.9k 0.9× 3.7k 0.8× 3.3k 1.1× 3.1k 1.3× 1.8k 0.9× 175 15.9k
Marco Presta Italy 71 11.0k 1.5× 2.3k 0.5× 3.4k 1.1× 3.0k 1.3× 2.9k 1.4× 330 17.4k
Olivier De Wever Belgium 54 6.5k 0.9× 3.9k 0.8× 1.2k 0.4× 3.0k 1.3× 1.5k 0.7× 225 12.0k
Mikala Egeblad United States 42 8.1k 1.1× 7.4k 1.6× 2.9k 0.9× 5.0k 2.1× 3.8k 1.8× 84 19.1k
Bruce R. Zetter United States 61 7.9k 1.1× 2.5k 0.5× 1.9k 0.6× 2.7k 1.1× 1.6k 0.8× 154 13.5k
Ellen Puré United States 71 5.5k 0.8× 4.4k 0.9× 2.6k 0.8× 2.4k 1.0× 5.1k 2.4× 173 15.4k
Reuven Reich Israel 59 5.4k 0.7× 3.0k 0.6× 1.3k 0.4× 3.4k 1.4× 1.8k 0.9× 202 11.2k

Countries citing papers authored by Jonathan P. Sleeman

Since Specialization
Citations

This map shows the geographic impact of Jonathan P. Sleeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan P. Sleeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan P. Sleeman more than expected).

Fields of papers citing papers by Jonathan P. Sleeman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan P. Sleeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan P. Sleeman. The network helps show where Jonathan P. Sleeman may publish in the future.

Co-authorship network of co-authors of Jonathan P. Sleeman

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan P. Sleeman. A scholar is included among the top collaborators of Jonathan P. Sleeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan P. Sleeman. Jonathan P. Sleeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Falkner, Florian, Benjamin Thomas, Patrick Heimel, et al.. (2023). Acellular Human Placenta Small-Diameter Vessels as a Favorable Source of Super-Microsurgical Vascular Replacements: A Proof of Concept. Bioengineering. 10(3). 337–337. 5 indexed citations
3.
Cavalli, Andrea, Jacopo Sgrignani, Jonathan P. Sleeman, et al.. (2022). CEMIP (HYBID, KIAA1199): structure, function and expression in health and disease. FEBS Journal. 290(16). 3946–3962. 20 indexed citations
4.
Rothley, Melanie, Anja Schmaus, Anja‐Katrin Bosserhoff, et al.. (2021). Quantitative Detection of Disseminated Melanoma Cells by Trp-1 Transcript Analysis Reveals Stochastic Distribution of Pulmonary Metastases. Journal of Clinical Medicine. 10(22). 5459–5459. 2 indexed citations
5.
Veselkov, Kirill, Jonathan P. Sleeman, Emmanuelle Claude, et al.. (2018). BASIS: High-performance bioinformatics platform for processing of large-scale mass spectrometry imaging data in chemically augmented histology. Scientific Reports. 8(1). 4053–4053. 33 indexed citations
6.
Schad, Arno, C. James Kirkpatrick, Jonathan P. Sleeman, et al.. (2016). Detection of cellular senescence within human invasive breast carcinomas distinguishes different breast tumor subtypes. Oncotarget. 7(46). 74846–74859. 16 indexed citations
7.
Schif‐Zuck, Sagie, Sonja Thaler, Tuan Zea Tan, et al.. (2016). ‘Normalizing’ the malignant phenotype of luminal breast cancer cells via alpha(v)beta(3)-integrin. Cell Death and Disease. 7(12). e2491–e2491. 15 indexed citations
8.
Mudduluru, Giridhar, Mohammed Abba, Jasmin Batliner, et al.. (2015). A Systematic Approach to Defining the microRNA Landscape in Metastasis. Cancer Research. 75(15). 3010–3019. 50 indexed citations
9.
Thiele, Wilko, et al.. (2014). Flow cytometry-based isolation of dermal lymphatic endothelial cells from newborn rats.. PubMed. 47(4). 177–86. 4 indexed citations
10.
Thaler, Sonja, et al.. (2014). The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancer. International Journal of Cancer. 137(3). 686–697. 27 indexed citations
11.
Heckmann, Doreen, Patrick Maier, Stephanie Laufs, et al.. (2013). The Disparate Twins: A Comparative Study of CXCR4 and CXCR7 in SDF-1α–Induced Gene Expression, Invasion and Chemosensitivity of Colon Cancer. Clinical Cancer Research. 20(3). 604–616. 44 indexed citations
12.
Quagliata, Luca, Natascha Cremers, Bronislaw Pytowski, et al.. (2013). Inhibition of VEGFR-3 activation in tumor-draining lymph nodes suppresses the outgrowth of lymph node metastases in the MT-450 syngeneic rat breast cancer model. Clinical & Experimental Metastasis. 31(3). 351–365. 15 indexed citations
13.
Sleeman, Jonathan P., Gerhard Christofori, Riccardo Fodde, et al.. (2012). Concepts of metastasis in flux: The stromal progression model. Seminars in Cancer Biology. 22(3). 174–186. 70 indexed citations
14.
Møller, Henrik Devitt, Natascha Cremers, Mika Frankel, et al.. (2011). Role of Fibulin-5 in Metastatic Organ Colonization. Molecular Cancer Research. 9(5). 553–563. 23 indexed citations
15.
Neeb, Antje, Natalia Novac, P. Schlag, et al.. (2011). The immediate early gene Ier2 promotes tumor cell motility and metastasis, and predicts poor survival of colorectal cancer patients. Oncogene. 31(33). 3796–3806. 40 indexed citations
16.
Anderegg, Ulf, Anja Saalbach, Linda Milkova, et al.. (2008). ADAM10 Is the Constitutive Functional Sheddase of CD44 in Human Melanoma Cells. Journal of Investigative Dermatology. 129(6). 1471–1482. 68 indexed citations
17.
Sleeman, Jonathan P., Jürgen Moll, Larry S. Sherman, et al.. (2007). The Role of CD44 Splice Variants in Human Metastatic Cancer. Novartis Foundation symposium. 189. 142–156. 4 indexed citations
18.
Baumann, Petra, Natascha Cremers, Frans G. M. Kroese, et al.. (2005). CD24 Expression Causes the Acquisition of Multiple Cellular Properties Associated with Tumor Growth and Metastasis. Cancer Research. 65(23). 10783–10793. 279 indexed citations
19.
Kirkin, Vladimir, Ralph Mazitschek, Jaya Krishnan, et al.. (2001). Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2. European Journal of Biochemistry. 268(21). 5530–5540. 2 indexed citations
20.
Kirkin, Vladimir, Ralph Mazitschek, Jaya Krishnan, et al.. (2001). Characterization of indolinones which preferentially inhibit VEGF‐C‐ and VEGF‐D‐induced activation of VEGFR‐3 rather than VEGFR‐2. European Journal of Biochemistry. 268(21). 5530–5540. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026